Related references
Note: Only part of the references are listed.Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
The Cardioprotective Effect of Mildronate is Diminished After Co-Treatment With L-Carnitine
Janis Kuka et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods
Amanda J. Lloyd et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Mildronate treatment alters γ-butyrobetaine and L-carnitine concentrations in healthy volunteers
Edgars Liepinsh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Mildronate, a Regulator of Energy Metabolism, Reduces Atherosclerosis in apoE/LDLR-/- Mice
Reinis Vilskersts et al.
PHARMACOLOGY (2009)
Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction
Edgars Liepinsh et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Disposition and metabolite kinetics of oral L-carnitine in humans
Marcus A. Bain et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis
MA Bain et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Mildronate: Cardioprotective action through carnitine-lowering effect
M Dambrova et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Share Paper
